NEW YORK, Nov. 20 Reportlinker.com announces that a new market research report is available in its catalogue.
Imaging Agents - A Worldwide Market Review
Advertisement
http://www.reportlinker.com/p0164325/Imaging-Agents---A-Worldwide-Market-Review.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire
Advertisement
Development of contrast agents revolutionized the visualization of organs within the human body. With their inherent ability to bring discrete organs and tissues to investigational scrutiny, imaging agents have undergone immense changes. Technology developments over the last two decades have expanded application roles of imaging agents. Major imaging technologies that presently utilize imaging agents include - x-ray/Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), ultrasound technologies. X-ray contrast media is paving way for emerging segments such as MRI, Ultrasound and diagnostic radiopharmaceuticals. The demand for imaging agents moves in sync with diagnosis and management of several age-related diseases including cancer, cardiovascular disease, and neurological disease. Reimbursement issues and procedural volumes are two key factors that significantly impact market dynamics.
These and other market data and trends are presented in "Imaging Agents: A Worldwide Market Review" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses
IMAGING AGENTS BMR-1125
CONTENTS
1. METHODOLOGY 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Quantitative Techniques & Reporting Level 3
2. GLOBAL MARKET OVERVIEW AND OUTLOOK 4
A Quick Primer On Imaging Agents 4
Growth Drivers 5
Growth Inhibitors 5
Changing Dynamics of Imaging Agents 6
Imaging Agents: Significant Growth Ahead 7
Rise of Non-Ionizing Imaging Techniques 8
Fusion Imaging Modalities: Greater Clinical Benefits 9
Radioactive Isotopes Utilized in PET & SPECT Imaging Procedures 10
Radiopharmaceuticals-An Exotic Tool 10
Nanomaterials Taking the Center Stage 10
Gadolinium Coated Nanoparticles- A Promising Imaging Agent 11
A Peek Into Pricing Dynamics 11
A Synoptic Overview 11
Pros & Cons 12
Positive Factors Driving Prices 12
Negative Factors Bearing Down on Prices 13
Reimbursements 13
"Under the Umbrella" 13
Europe 13
United States 14
3. MARKET TRENDS & ISSUES 15
Falling Prices Turn On the Heat 15
X-Ray Contrast Media: Declining Sector 15
MRI Contrast Media: Playing at Center Court 15
Impact Wielded by Ballooning MRI Practices 16
Ultrasound Contrast Media: A Rising Star in the Quadrant 16
Fledging Market Battles Teething Challenges 17
PET: A Prime Growth Driver for Radiopharmaceuticals 18
Nuclear Medicine: A Potential Growth Avenue for
Radiopharmaceuticals 18
Select Cardiology and Oncology Radiopharmaceuticals 19
4. COMPETITION 20
Market Structure 20
Market Participants 20
Key Market Metrics 21
Big Guns in the Emerging MRI Market 21
Bayer Schering Pharma AG: A Pioneering Developer of MRI
Contrast Agents 22
Competitive Scenario - A Recent Past Perspective 22
5. TECHNOLOGY BREAKTHROUGHS 24
Molecular Imaging Agents: The Outer Limits 24
On Cards: Hyperpolarized Gases as Contrast Agents 24
Imaging Agents Make a Welcome Impact in the Field of
Alzheimer's Disease 25
Technetium-99m: A Breakthrough Contrast Agent for CNS Imaging 25
A New Imaging Agent for Radiopharmaceutical Scans 25
Multi-Modal Image Registration: Combating Contrast Medium
Inconsistencies 26
Saline Flushes To Help Ensure Accurate Delivery of Contrast
Agents 26
6. PRODUCT FACTS 27
A. Contrast Media 27
X-Ray Contrast Media 27
Magnetic Resonance Imaging (MRI) Contrast Media 27
Ultrasound Contrast Media 27
B. Diagnostic Radiopharmaceuticals 27
7. TECHNOLOGY DYNAMICS 28
New Proprietary Technologies on the Horizon Making Significant
Inroads 28
8. CORPORATE DEVELOPMENTS 29
Bristol-Myers Squibb Medical Imaging Adopts New Identity,
Lantheus Medical Imaging 29
Cytogen Corporation to Merge Business with EUSA Pharma Inc 29
Bracco Group Acquires E-Z-EM 29
EPIX Pharmaceuticals to Resubmit New Drug Application (NDA)
for Vasovist 29
Bayer Schering, FutureChem Ink Licensing Deal 30
NuView Radio Pharmaceuticals Inks Agreement for Non-Invasive
Imaging Agent 30
Bayer to Unleash Radiology Management System 30
Bayer to Unveil Pre-Filled Contrast-Medium Cartridges for MRI 30
Advanced Magnetics Inc Changes Name to AMAG Pharmaceuticals 30
Bracco Diagnostics Inks Agreement with HealthTrust Purchasing
Group 31
Bracco Diagnostics Offers MRI Products to HealthTrust
Purchasing Group 31
Bayer HealthCare Offers MRI Contrast Agent to HealthTrust 31
Bayer HealthCare Extends Contract with Premier 31
Bayer HealthCare Sets Off US Operations 31
Tyco Healthcare Renamed to Covidien Ltd 31
Covidien Offers Imaging Solutions to MedAssets Supply Chain
Systems 32
Siemens, M.D. Anderson Cancer Center Set up Research Centre 32
Bayer, Berlex Merge Operations 32
AION Diagnostics Forays Pre-Clinical Imaging Agent Market 32
Insight Agents to Launch Generic Contrast Media Solutions In
Europe 32
Researchers Develop First Biocompatible MRI Contrast Agent 33
9. MAJOR PLAYERS 33
AMAG Pharmaceuticals Inc (USA) 33
Amersham Plc (UK) 33
Bayer Schering Pharma AG (Germany) 33
Bayer HealthCare Pharmaceuticals (US) 34
Bracco Group (Italy) 34
E-Z-EM Inc. (USA) 34
Covidien (USA) 34
Cytogen Corp. (USA) 34
Daiichi Sankyo Company Limited (Japan) 35
Eisai Co., Ltd. (Japan) 35
EPIX Pharmaceuticals Inc. (USA) 35
Guerbet Group (France) 35
Lantheus Medical Imaging (USA) 35
10. GLOBAL MARKET ANALYTICS 36
11. THE UNITED STATES 43
Growth Stimulants 43
Medical Imaging: Changing the Healthcare Landscape 43
Dynamics of Pricing 43
Reimbursement Issues 44
Medicare 44
Magnetic Resonance Imaging 45
Regulatory Environment 46
Provisions Regarding Off-Label Usage of Contrast Media 47
Contrast Media 47
X-ray Contrast Media 47
MRI Contrast Media 47
Market Scenario 47
Managed Care Vs MRI Technology Diffusion 48
Ultrasound Contrast Media 48
Diagnostic Radiopharmaceuticals 48
Market Scenario 48
Availability of Isotopes: A Tough Challenge 48
12. CANADA 50
Diagnostic Equipment Market 50
LOCM Products Approved in Canada 50
13. JAPAN 52
Reimbursement Issues 52
14. EUROPE 53
a. France 59
b. Germany 60
c. The United Kingdom 61
d. Italy 62
e. Spain 63
f. Russia 64
g. Rest of Europe 65
15. ASIA-PACIFIC 66
PET Imaging-An Overview 67
ANSTO: Leading the Radiopharmaceuticals Market 67
16. THE MIDDLE EAST 68
17. LATIN AMERICA 69
EXHIBITS
Table 1: Percentage Breakdown of Leading Imaging Agents
Manufacturer Value Sales in the World - 2003
Table 2: Breakdown of Medical Diagnostic Procedures by Imaging
Modality Type in the World - 2003
Table 3: Percentage Breakdown of Leading Imaging Agents
Manufacturer Value Sales in the World - 2004
Table 4: Percentage Market Shares of Leading X-ray Medical
Diagnostics Manufacturers in the World - 2004
Table 5: Percentage Market Shares of Leading MRI Diagnostics
Manufacturers in the World - 2004
Table 6: Percentage Market Shares of Leading
Radiopharmaceutical Medical Diagnostics Manufacturers in the
World - 2004
Table 7: Global Imaging Agents Market by Region for the Period
2007-2015 (Sales in US$ Million)
Table 8: Percentage Breakdown of Global Imaging Agents Market
by Region for the Years 2008 & 2012
Table 9: Global Contrast Media Market by Region for the Period
2007-2015 (Sales in US$ Million)
Table 10: Percentage Breakdown of Global Contrast Media Market
by Region for the Years 2008 & 2012
Table 11: Global Contrast Media Market by Segment for the
Period 2007-2015 (Sales in US$ Million)
Table 12: Percentage Breakdown of Global Contrast Media Market
by Segment for the Years 2008 & 2012
Table 13: Global X-Ray Contrast Media Market by Region for the
Period 2007-2015 (Sales in US$ Million)
Table 14: Percentage Breakdown of Global X-Ray Market by
Region for the Years 2008 & 2012
Table 15: Global MRI Contrast Media Market by Region for the
Period 2007-2015 (Sales in US$ Million)
Table 16: Percentage Breakdown of Global MRI Market by Region
for the Years 2008 & 2012
Table 17: Global Ultrasound Contrast Media Market by Region
for the Period 2007-2015 (Sales in US$ Million)
Table 18: Percentage Breakdown of Global Ultrasound Market by
Region for the Years 2008 & 2012
Table 19: Global Diagnostic Radiopharmaceuticals Market by
Region for the Period 2007-2015 (Sales in US$ Million)
Table 20: Percentage Breakdown of Global Diagnostic
Radiopharmaceuticals Market by Region for the Years 2008 &
2012
Table 21: Percentage Breakdown of Hospital Purchases by Type
in the US - 2002
Table 22: Imaging Agents Market by Segment in the US:
2007-2015 (Sales in US$ Million)
Table 23: Percentage Breakdown of Imaging Agents Market by
Segment in the US for the Years 2008 & 2012
Table 24: Imaging Agents Market by Segment in Canada:
2007-2015 (Sales in US$ Million)
Table 25: Percentage Breakdown of Imaging Agents Market by
Segment in Canada for the Years 2008 & 2012
Table 26: Imaging Agents Market by Segment in Japan: 2007-2015
(Sales in US$ Million)
Table 27: Percentage Breakdown of Imaging Agents Market by
Segment in Japan for the Years 2008 & 2012
Table 28: Imaging Agents Market by Region in Europe: 2007-2015
(Sales in US$ Million)
Table 29: Percentage Breakdown of Imaging Agents Market by
Region in Europe for the Years 2008 & 2012
Table 30: Imaging Agents Market by Segment in Europe:
2007-2015 (Sales in US$ Million)
Table 31: Percentage Breakdown of Imaging Agents Market by
Segment in Europe for the Years 2008 & 2012
Table 32: Imaging Agents Market by Segment in France:
2007-2015 (Sales in US$ Million)
Table 33: Percentage Breakdown of Imaging Agents Market by
Segment in France for the Years 2008 & 2012
Table 34: Imaging Agents Market by Segment in Germany:
2007-2015 (Sales in US$ Million)
Table 35: Percentage Breakdown of Imaging Agents Market by
Segment in Germany for the Years 2008 & 2012
Table 36: Imaging Agents Market by Segment in the UK:
2007-2015 (Sales in US$ Million)
Table 37: Percentage Breakdown of Imaging Agents Market by
Segment in the UK for the Years 2008 & 2012
Table 38: Imaging Agents Market by Segment in Italy: 2007-2015
(Sales in US$ Million)
Table 39: Percentage Breakdown of Imaging Agents Market by
Segment in Italy for the Years 2008 & 2012
Table 40: Imaging Agents Market by Segment in Spain: 2007-2015
(Sales in US$ Million)
Table 41: Percentage Breakdown of Imaging Agents Market by
Segment in Spain for the Years 2008 & 2012
Table 42: Imaging Agents Market by Segment in Russia:
2007-2015 (Sales in US$ Million)
Table 43: Percentage Breakdown of Imaging Agents Market by
Segment in Russia for the Years 2008 & 2012
Table 44: Imaging Agents Market by Segment in Rest of Europe:
2007-2015 (Sales in US$ Million)
Table 45: Percentage Breakdown of Imaging Agents Market by
Segment in Rest of Europe for the Years 2008 & 2012
Table 46: Imaging Agents Market by Segment in Asia-Pacific:
2007-2015 (Sales in US$ Million)
Table 47: Percentage Breakdown of Imaging Agents Market by
Segment in Asia-Pacific for the Years 2008 & 2012
Table 48: Imaging Agents Market by Segment in Middle East:
2007-2015 (Sales in US$ Million)
Table 49: Percentage Breakdown of Imaging Agents Market by
Segment in Middle East for the Years 2008 & 2012
Table 50: Imaging Agents Market by Segment in Latin America:
2007-2015 (Sales in US$ Million)
Table 51: Percentage Breakdown of Imaging Agents Market by
Segment in Latin America for the Years 2008 & 2012.
COMPANIES PROFILED
To order this report:
Imaging Agents - A Worldwide Market Review
http://www.reportlinker.com/p0164325/Imaging-Agents---A-Worldwide-Market-Review.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire
More market research reports here!
Nicolas BombourgReportlinkerEmail: [email protected]: (805)652-2626Intl: +1 805-652-2626
SOURCE Reportlinker
